Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2021-02-26
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Coherent Optical Detection of Middle Ear Disease
NCT05353569
Clinical Evaluation of the OtoSight
NCT03890107
Diagnostic Utility of Otosight Middle Ear Scope
NCT05641285
Does Tympanometry Predict Antibiotic Usage in Acute Otitis Media?
NCT01941381
Validating and AI Software for Assessment of Children With Ear Concerns
NCT07243093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Medical Tool
Spectroscopic otoscope
Spectroscopic otoscope measurements
Spectroscopic otoscope measurements are taken with the investigational device. Each measurement consists of placing the device in the ear canal and illuminating the ear with multiple light sources in a short period of time. If wax is present in the ear canal, it is removed by the study physician and another measurement is taken.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spectroscopic otoscope measurements
Spectroscopic otoscope measurements are taken with the investigational device. Each measurement consists of placing the device in the ear canal and illuminating the ear with multiple light sources in a short period of time. If wax is present in the ear canal, it is removed by the study physician and another measurement is taken.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Non- pregnant woman.
3. Diagnose of middle ear infection and plan for surgery procedure.
Exclusion Criteria
2. Incompetent adults (i.e. individuals with cognitive impairment)
3. No diagnose of middle ear infection and no plan for surgery procedure.
4. Adults with cognitive impairment and children of parents that are cognitively impaired and thus are unable to consent will be excluded from the study.
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elliot L Botvinick
Professor of Biomedical Engineering and Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elliot Botvinick
Role: PRINCIPAL_INVESTIGATOR
University of Calfornia Irvine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Orange County (CHOC)
Orange, California, United States
UCI Otolaryngology Clinic
Orange, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gurpreet Ahuja, MD
Role: primary
Hamid Djalilian, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20163039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.